Drug intelligence / Profile preview

nerindocianine

Development stage
Discontinued
Lead developer
LI-COR Biosciences
Modality
Small Molecules
Administration
Intravenous
01

Overview

Nerindocianine (formerly known as IRDye 800BK) is a near-infrared (NIR) fluorescent imaging agent developed by LI-COR Biosciences for use as a surgical aid. It is a synthetic cyanine dye designed to improve the intraoperative visualization and delineation of urologic anatomy, specifically the ureters, during minimally invasive abdominal and pelvic surgeries. Unlike indocyanine green (ICG), which is primarily cleared by the liver, nerindocianine is cleared by the kidneys and excreted into the urine. This renal clearance profile allows for real-time fluorescence imaging of the urinary tract using NIR camera systems, helping surgeons identify and avoid accidental ureteral injury during complex procedures such as colorectal, gynecological, or urological surgeries. The agent is currently being evaluated in Phase 2 clinical trials to establish its safety and efficacy in delineating abdominopelvic ureter anatomy.

Brand names
IRDye 800BKIRDye800BKIRDye-800BK
Other names
IRDye 800BK-CarboxylateIRDye800BK-CarboxylateIRDye-800BK-Carboxylatenerindocianine green

Beyond the preview

Go deeper on nerindocianine.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on nerindocianine.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call